WO1997001985A1 - Apparatus for determining spectral absorption - Google Patents
Apparatus for determining spectral absorption Download PDFInfo
- Publication number
- WO1997001985A1 WO1997001985A1 PCT/US1995/008343 US9508343W WO9701985A1 WO 1997001985 A1 WO1997001985 A1 WO 1997001985A1 US 9508343 W US9508343 W US 9508343W WO 9701985 A1 WO9701985 A1 WO 9701985A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pulse oximeter
- light
- voltage
- energy
- probe
- Prior art date
Links
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 14
- 230000003595 spectral effect Effects 0.000 title claims abstract description 13
- 239000012530 fluid Substances 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 8
- 239000000523 sample Substances 0.000 claims description 104
- 239000008280 blood Substances 0.000 claims description 38
- 210000004369 blood Anatomy 0.000 claims description 38
- 230000008033 biological extinction Effects 0.000 claims description 25
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 23
- 239000001301 oxygen Substances 0.000 claims description 23
- 229910052760 oxygen Inorganic materials 0.000 claims description 23
- 230000002792 vascular Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 description 13
- 230000003287 optical effect Effects 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 9
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 244000078856 Prunus padus Species 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000003990 capacitor Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005496 eutectics Effects 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- -1 Alcryn Chemical compound 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
- A61B5/02427—Details of sensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
Definitions
- the present invention is generally directed to an apparatus for determining spectral absorption by a particular substance m a fluid. Specifically, the present invention is directed to a probe apparatus for sensing arterial pulse and blood oxygen saturation m a patient. BACKGROUND OF THE INVENTION
- a system is needed for non-mvasively monitoring pulse and arterial blood oxygen saturation m a patient.
- pulse rate and blood oxygen saturation are routinely monitored m a patient undergoing surgery or receiving emergency medical treatment.
- Blood pressure and pulse rate provide essential information about the functioning of the patient's cardiovascular system.
- Blood oxygen saturation provides information about the patient's ventilation; thus, blood oxygen saturation is a key indicator of the patient's health, whether the patient is human or another animal
- the chemical composition of blood can be determined by drawing blood samples and employing well-known chemical analysis techniques.
- a non-invasive technique m which no blood is drawn, is preferred, since drawing blood from a patient adds additional trauma to the patient.
- analysis of the blood can be an expensive and time consuming procedure and may require elaborate chemical analysis equipment. Such time and equipment may not be readily available, particularly m the context of a medical emergency at a site remote from a hospital or other health care facility.
- a better technique uses a non-invasive probe which may be disposed after one or a few uses and is simple and inexpensive to manufacture and use. Using such a non ⁇ invasive probe yields routinely required information, such as pulse and blood oxygen saturation, by a simple, routine and portable measurement technique.
- Kirschbaum' s sensing apparatus is linked to an additional oxygen administering apparatus which limits its portability. Kirschbaum makes no provision for a disposable probe. Additionally, Kirschbaum' s probe must be recalibrated for each use to account for differences in each patient and differences in the lamps used in the probe.
- Smith also uses the data derived from the probe to provide blood pressure information.
- the oximeter of Smith uses a light bulb as a source of red and infrared energy.
- Use of an expensive, fragile element such as a light bulb limits the ruggedness and disposability of the Smith device and renders it unsuitable, for example, for emergency medical treatment at remote locations.
- Infrared light has also been used to measure the concentration of blood analytes.
- near-infrared light having a wavelength greater than 1800 nanometers (nm) is directed into a body part of a patient and sensed to determine the concentration of analytes such as glucose in the blood.
- determination of oxygen saturation is preferably achieved using both red and infrared light energy at wavelengths less than 1000 nm.
- the probes of Kirschbaum, Liston, Smith and Schlager are preferably attached to the ear of a patient.
- U.S. Patent No. 4,865,038 to Rich et al . for "Sensor Appliance for Non-invasive Monitoring” discloses a flexible probe which may be removably attached to a finger or other appendage. This probe has the advantage of providing the ability to conform to the appendage while maintaining secure attachment thereto. For medical procedures involving the head and neck, the ear probe could be inconvenient and create interference with access to the head and neck. The ability to attach the probe to a finger, toe or other appendage provides added flexibility and convenience, allowing the probe to be kept from interfering with other procedures.
- U.S. Patent No. 4,825,872 to Tan et al . for "Finger Sensor for Pulse Oximetry System” discloses a similar probe which is retained on the finger by means of expansive side panels which expand and contract appropriately to engage the finger.
- Rich et al also disclose the use of solid state devices to generate the red and infrared light energy directed into the patient's blood, and solid state optical sensors to detect light not absorbed by the blood.
- solid state devices to generate the red and infrared light energy directed into the patient's blood
- solid state optical sensors to detect light not absorbed by the blood.
- LEDs semiconductor light emitting diodes
- the transmission of light having a wavelength of approximately 660 nm (i.e., red light) through blood is strongly affected by the amount of oxygenerated hemoglobin present in the blood.
- the transmission of light having a wavelength of approximately 940 nm is not substantially affected by the amount of oxygenated hemoglobin present.
- An oximeter determines blood oxygen saturation based on the intensity of light received by an optical sensor and the known wavelength of an LED.
- the wavelength of the absorbed light defines an extinction coefficient which the oximeter uses in calculating blood oxygen concentration in a manner known in the art. Consequently, the oximeter must be calibrated to the wavelength of the LEDs employed m the probe.
- different wavelengths of LED light require coefficients having different values be employed for determining blood oxygen concentration. That is, if a probe with a first LED having a first wavelength is replaced by a probe with a second LED having a different second wavelength, the oximeter must use a different coefficient in calculating blood oxygen saturation. An oximeter using such a probe must be recalibrated, therefore, whenever a probe is changed, in order to maintain consistency of measurement and accuracy of results.
- the New oximeter uses a corresponding look up table located m semiconductor memory m the oximeter to determine the appropriate wavelength of the LEDs m the probe and to select the requisite extinction coefficients
- the wavelength tolerance of the LEDs is large relative to the range permitted by the oximeter.
- the manufacturing tolerance of the LEDs might be ⁇ 20 nm. That is, a LED specified by the manufacturer as having a wavelength of 660 nm actually has a wavelength somewhere m the range from 640 nm to 680 nm
- the oximeter must effect calculations based on the actual LED wavelengths withm a tolerance of less than 5 nm. Consequently, the use of the resistor to encode the wavelength value is a necessary step m providing a disposable probe. Without the resistor present to encode the LED wavelengths, the New oximeter does not function.
- New provided for the use of low cost LEDs with a large manufacturing tolerance and a resistor to encode the exact values of the LED wavelengths within their tolerance ranges .
- oximeter systems typically do not rely on encoding the LED wavelength values .
- Manufacturing techniques for LEDs have improved so that LEDs having a tight tolerance--as low as + 2 nm--are inexpensively available. Consequently, the encoding and look up table disclosed m New are not required m competing oximeter systems. Competing systems specify a center value for the LED wavelengths, as for example, 660 nm and 940 nm, and each conforming probe is then supplied with LEDs having those wavelengths.
- the oximeter probe disclosed by New has several shortcomings. To keep manufacturing cost low, the encoding resistor has a large tolerance and a large temperature coefficient of resistance.
- Oximeter systems are used not only in the controlled environments of operating rooms but, also, in the emergency medical treatment context, in situations of environmental temperature extremes.
- the operating temperature of such a system may range from well below zero degrees Fahrenheit to well over one hundred degrees Fahrenheit. Under such extremes, a more precise means of interfacing the probe to the oximeter is needed.
- the probe disclosed by New is subject to noise which may cause incorrect readings .
- Low frequency noise may be misinterpreted by the oximeter to be pulsatile information.
- Such noise may have its source in radio frequency radiation propagated through the environment, as from other nearby test equipment, or as a motion artifact, due to movement of the bodily appendage to which the probe is attached.
- a probe which avoids the encoding technique disclosed by New also provides manufacturing economies.
- the use of tight-tolerance LEDs eliminates the need to maintain multiple stocks of different wavelength LEDs.
- a single bin of devices can be used, reducing storage costs.
- the necessary step of testing LED wavelengths is eliminated.
- the step of matching a resistor to the LED wavelength is eliminated.
- Using precision LEDs and eliminating the encoding resistor greatly reduces manufacturing cost and complexity.
- an oximeter probe which can accurately interface with multiple types of oximeter systems, including those which use an encoding resistor and those which specify a center wavelength value, as well as providing precise measurement characteristics in extreme as well as nominal environments, has reduced sensitivity to noise interference, and which is inexpensive enough to manufacture so as to be economically disposable after one or a few uses .
- the present invention provides an apparatus for determining spectral absorption by a specific substance in a fluid and indicating the spectral absorption to a remote display device.
- the apparatus of the present invention comprises an energy source which emits energy having one or more characteristic wavelengths; a sensing device for sensing the energy emitted by the energy source and producing an electrical output which represents the spectral absorption of the energy by the substance; an interface device which generates a reference voltage which reference voltage interacts with the remote display device; a support structure for supporting the other elements in proximity to the fluid; and a connector for communicating the electrical output to the remote display device.
- the energy source comprises at least one light emitting diode.
- the energy source emits both red light and infra-red light.
- the interface means comprises a voltage regulator.
- the present invention further provides a pulse oximeter probe for non-invasively determining vascular oxygen saturation and pulse frequency in a patient.
- the pulse oximeter probe of the present invention comprises one ⁇ r more light emitting diodes which direct light having a predetermined wavelength into tissue of the patient; a sensor which senses the light directed by the light emitting diodes and produces an electrical signal which reflects the amount of energy sensed; a voltage source which generates a substantially constant output voltage, which voltage reflects the predetermined wavelength of the light emitting diodes; and an assembly structure which supports the other elements adjacent the tissue of the patient .
- the light emitting diodes of the pulse oximeter probe of the present invention emit light having wavelengths corresponding to red and infrared light.
- the voltage source is preferably independent of variations in supply voltage and temperature.
- the pulse oximeter preferably includes a connector for communicating the electrical signal from the sensor and the output voltage from the voltage source to a remote display device.
- the present invention still further provides a pulse oximeter probe for non-invasively sensing the arterial pulse frequency and percent oxygen saturation of the blood of a living patient and communicating with a display device.
- the pulse oximeter probe of the present invention comprises one or more light emitting diodes, which are responsive to the display device, which direct light energy into the tissue of the patient, the light energy being partly absorbed by the blood of the patient according to a known extinction coefficient corresponding to the predetermined wavelength and being partly reflected by the blood; a sensor which senses the intensity of light energy from the light emitting diodes and not absorbed by the blood and converts the intensity of the light energy to an electrical signal; a precision voltage regulator means which generates a voltage reflecting the predetermined wavelength and the extinction coefficient, which voltage is substantially independent of variations in temperature or supply voltage and electrical noise, and which voltage cooperates interactively with the display device; a support structure for detachably supporting the one or more ligr-c emitting diodes, the sensor, and the precision voltage regulator adjacent the tissue of the patient;
- the support structure of the pulse oximeter probe of the present invention comprises a structure for attaching the probe to the patient's finger.
- the light emitting diodes are responsive to a control signal from the display device, which control signal is preferably communicated from the display device to the light emitting diodes by means of nhe connector.
- FIG. 1 is a perspective view of a pulse oximeter probe employing the preferred embodiment of the present invention.
- Fig. 2 is an exploded perspective view of a pulse oximeter probe employing the preferred embodiment of the present invention.
- Fig. 3 is a top view of the chassis of a pulse oximeter probe employing the present invention.
- Fig. 4 is a side view of the chassis of Fig. 3 taken at section AA of Fig. 3.
- Fig. 5 s a top view of the printed circuit board of a pulse oximeter probe employing the preferred embodiment of present invention.
- Fig. 6 is a top view of the interface module of a pulse oximeter probe employing the preferred embodiment of the present invention.
- Fig. 7 is a schematic diagram of the circuit of a pulse oximeter probe employing the preferred embodiment of the present invention.
- FIG 1 is a perspective view of a pulse oximeter probe employing the preferred embodiment of the present invention.
- pulse oximeter probe 10 includes an assembly 12 and a connector 14.
- Connector 14 provides electrical connection to the remote pulse oximeter, not shown, as well as mechanical support and strain relief for assembly 12.
- Assembly 12 includes first finger locator 16 and second finger locator 18. Finger locators 16 and 18 are depressions formed in assembly 12 which allow probe 10 to grippingly engage a patient's finger. Probe 10 may also engage the patient's toe or other bodily appendage. Assembly 12 is preferably formed of a flexible material which is impervious to dirt and grease and which may be readily wiped clean with water or alcohol, such as Alcryn, sold by DuPont Corp.
- assembly 12 is shown in its stored, unflexed position. In use, assembly 12 preferably flexes along centeriine 24. In this manner, first finger locator 16 engages the lower surface of the patient's finger and second finger locator 18 engages the upper surface of the patient's finger. Attached to assembly 12 are tie down tabs 28. The underside of tie down tabs 28 is coated with an adhesive material 30. When probe 10 is not in use, adhesive material 30 is protectively covered by paper strips 26. Paper strips 26 prevent dirt and other contaminants from contacting adhesive material 30. When probe 10 is placed on a patient's finger, assembly 12 is flexed along centeriine 24 allowing finger locators 16, 18 to engage the patient's finger. Paper strips 26 are removed, exposing adhesive material 30.
- Tie down tabs 28 are then folded up so as to secure assembly 12 in place on the patient's finger. Tie down tabs 28 attach to assembly 12 and to one another by means of adhesive material 30. Preferably, probe 10 is held firmly in place on the patient's finger so as to ensure a fit which does not impede blood circulation in the patient's finger. Use of adhesive material 30 allows probe 10 to be reused multiple times on one or more patients before being discarded.
- Assembly 12 includes LED mount 20 and sensor mount 22.
- One or more light emitting diodes 32 are mounted in LED mount 20.
- two light emitting diodes 32 are mounted in LED mount 20.
- An optical sensor 34 sensitive to the wavelengths of light emitted by light emitting diodes 32 mounted in LED mount 20, is mounted in sensor mount 22.
- Optical sensor 34 preferably converts the intensity of light striking optical sensor 34 into an electrical signal, such as an electrical current.
- probe 10 is fitted to a patient's finger.
- Light emitting diodes 48, 49 respond to signals communicated by connector 14 from a remote pulse oximeter.
- Light emitting diodes 48, 49 direct light of a predetermined wavelength into the patient's finger.
- light emitting diodes 48, 49 might direct red light having a wavelength of 660 nm and infrared light having a wavelength of 2940 nm into the patient's finger.
- some of the light is absorbed by the oxygenerated hemoglobin in the patient's blood.
- Some of the light is reflected and diffused through the patient's finger and strikes optical sensor 34.
- Optical sensor 34 produces an electrical signal reflecting the intensity of the light striking optical sensor 34. The electrical signal is communicated by means of connector 14 to the remote pulse oximeter which determines the percent oxygen saturation of the patient's blood and produces an appropriate display.
- Fig. 2 is an exploded perspective view of a pulse oximeter probe employing the preferred embodiment of the present invention.
- chassis 40 forms the base for probe 10.
- Chassis 40 is preferably molded from a flexible material, such as Alcryn.
- Printed circuit board 38 is mounted on chassis 40.
- Printed circuit board 38 is preferably formed of a flexible material such as mylar.
- Connector 14 is attached to printed circuit board 38.
- Connector 14 is attached both electrically and mechanically to circuit board 38.
- Flexible laminate 36 is attached to chassis 40 so as to completely enclose printed circuit board 38.
- Printed circuit board 38 is thereby protected from contamination.
- Fig. 3 is a top view of chassis 40.
- Fig.- 3 show ⁇ light emitting diode mount 20 in line with sensor mount 22 and voltage source mount 42.
- Light emitting diode mount 20 and sensor mount 22 preferably comprise perforations in chassis 40.
- Voltage source mount 42 preferably comprises a depression in chassis 40. These provide mechanical clearance for the active circuit components mounted on printed circuit board 38.
- Fig. 4 is a side view of chassis 40 in partial section taken at section AA of Fig. 3.
- Fig. 4 shows curved faces 44, 46 in the upper surface of chassis 40. Curved face 44 is located at first finger locator 16. Curved face 46 is located at second finger locator 18. When probe 10 is in place on a patient's finger, curved faces 44, 46 engage the surface and edges of the finger to prevent lateral slippage.
- Fig. 5 is a top view of printed circuit board 38 of a pulse oximeter probe employing the present invention.
- Fig. 5 shows preferred dimensions of printed circuit board 38.
- Traces 52 are located on the surface of printed circuit board 38 and are preferably formed of a flexible or malleable electrical conductor such as copper. When probe 10 is in use, traces 52 are in electrical contact with connector 14, not shown. Traces 52 carry electrical signals, power supply voltages and ground potential between the active components of probe 10 and connector 14.
- Fig. 5 also shows light emitting diodes 48, 49 mounted on printed circuit board 38. Light emitting diodes 48, 49 are fixedly attached to printed circuit board 38, for example, by eutectic bonding. Preferably, light emitting diodes 48, 49 emit light having a wavelength corresponding to red light and light having a wavelength corresponding infrared light.
- Fig. 5 shows sensor mount 22 and module mount 50 on printed circuit board 38.
- Fig. 6 is a top view of interface module 54 of a pulse oximeter probe employing the preferred embodiment of the present invention.
- Interface module 54 is rigidly attacned to printed circuit board 38 at module mount 50, for example, by eutectic bonding
- Voltage regulator 56 is mounted on interface module 54
- Voltage regulator 56 is preferably configured as an integrated circuit.
- Interface module 54 also includes resistor 58 and resistor 60.
- Resistors 58, 60 are preferably formed from conductive ink printed on the surface of interface module 54. When interface module 54 is assembled and tested, resistors 58, 60 may preferably be trimmed to a precise value. Laser trimming ensures that resistors 58, 60 have a manufacturing tolerance of ⁇ 1%.
- Interconnect metal 62 is located on the surface of interface module 54 and connects resistors 58, 60 and voltage regulator 56.
- interface module 54 includes IN terminal 64, OUT terminal 66, ADJUST terminal 68, SENSE terminal 70, VOUT terminal 72 and ground connection terminal 73. These terminals 64, 66, 68, 70, 72, 73 connect to printed circuit board 38. Voltage regulator 56 is connected to these terminals 64, 66, 68, 70, 72, 73 by wire bonds 74.
- Fig. 7 is a schematic diagram of the circuit of a pulse oximeter probe employing the preferred embodiment of the present invention.
- terminals 78, 80, 82, 84, 86 are coupled to connector 14.
- Fig. 7 shows light emitting diodes 48, 49, optical sensor 34, voltage regulator 56, resistors 58, 60 and capacitor 76.
- Light emitting diodes 48, 49 are coupled between terminals 78, 80 and terminal 86.
- Optical coupler 30 is coupled between terminal 82 and terminal 86.
- Terminal 88 is preferably coupled to IN terminal 64 of interface module 54 (see Fig. 6) .
- Terminal 84 is preferably coupled to OUT terminal 66 cf interface module 54 (Fig. 6) .
- Terminal 84 is preferably coupled to ground connection 73 of interface module 54 (Fig. 6) .
- Terminal 86 is preferably coupled to system ground.
- terminal 88 is coupled to a system voltage (not shown) preferably m the range of 0 to 5 volts.
- Capacitor 76 filters low and high frequency electrical noise from the output voltage generated at terminal 84. Such noise may have its source in radio frequency radiation caused by other nearby test equipment or as a motion artifact, as when probe 10 is attached to a moving patient, such as an infant, causing the probe to move m relation to tne patient.
- voltage regulator 56 is a precision adjustable voltage regulator which preferably provides an output voltage at terminal 84 which is substantially invariant with variations m temperature and supply voltage and maintains these characteristics over an operating range from approximately -55° to approximately -rl50°C.
- light emitting diodes 48, 49 receive signals from the remote pulse oximeter (not shown m Fig. 7) by means of connector 14.
- light emitting diodes 48, 49 direct red and infrared light into the tissue of the patient. A portion of the emitted light is absorbed by the oxygenated hemoglobin in the patient's blood. The balance of the light passes through the tissue and is incident on optical sensor 34.
- Optical sensor 34 senses the intensity of the incident light and generates an electrical signal representing that intensity. The electrical signal is communicated to the remote pulse oximeter via connector 14.
- the remote pulse oximeter receives the electrical signals and calculates percent oxygen saturation in a manner known in the art.
- the calculation includes use of extinction coefficients which are dependent for their value on the wavelength of the incident light.
- Many commercially available pulse oximeter systems specify standard values for the wavelength of the light to be emitted by the light emitting diodes contained in conforming probes, for example, a red LED having a wavelength of 660 nm and an infrared LED having a wavelength of 904 nm.
- the oximeter system uses extinction coefficients corresponding to the specified LED wavelengths to calculate percent oxygen saturation.
- pulse oximeter systems do not specify a particular LED wavelength for conforming probes but rather specify a range of wavelengths.
- the probe must then additionally include an encoding means such as a resistor to communicate to the oximeter system the exact values of wavelength of the LEDs assembled with the probe.
- the pulse oximeter in such a system includes a constant current source which passes current through the encoding resistor, generating a reference voltage which can be read by the pulse oximeter system.
- the pulse oximeter system uses the reference voltage to determine, from a look up table located in semiconductor memory, the appropriate extinction coefficient.
- inexpensive LEDs having a wide tolerance, such as ⁇ nm are inexpensively available.
- light emitting diodes 48, 49 can be chosen when probe 10 is assembled to correspond to the specified values. In applications in which probe 10 is used with such pulse oximeter systems, voltage regulator 56 does not interfere with the system.
- voltage regulator 56 In pulse oximeter systems which permit a range of LED wavelengths to be used and require a reference voltage from the probe to identify the wavelength of LEDs employed in the probe, voltage regulator 56 generates the required reference voltage and configures probe 10 to interface with the pulse oximeter system. Thus, voltage regulator 56, with resistors 58, 60, generates a precisely regulated voltage at terminal 84 reflecting the wavelengths of light emitting diodes 48, 49. The pulse oximeter system uses the regulated voltage on terminal 84 to determine the appropriate extinction coefficients.
- voltage regulator 56 and resistors 58, 60 provides distinct advantages over prior art designs, such as oximeter probes using an encoding resistor. Except for precision resistors, the cost of which would be prohibitively high for manufacturing a competitively priced oximeter probe which could be economically discarded after one or a few uses, resistors generally exhibit great variation in their value with temperature and offer an inacceptably wide tolerance in their specified value.
- a pulse oximeter system may be used in providing emergency medical treatment away from a controlled hospital environment, often at extremes of temperature. In such circumstance, the value of a resistor may vary too greatly to reliably accurately establish a reference voltage for an oximeter, thereby causing the wrong extinction coefficients to be employed by the oximeter so that incorrect conclusions may result from measurements taken.
- voltage regulator 56 In contrast to such unreliable operation by a resistor, voltage regulator 56 generates a temperature and voltage compensated reference voltage. Resistors 58, 60 may be laser trimmed during manufacturing ensuring accuracy within one percent of a specified value for a reference voltage. Thus, with the present invention, the proper reference voltage is always presented by the probe to the remote pulse oximeter system, thereby assuring correct values for extinction coefficients are employed by the oximeter system. In addition, capacitor 76 filters electrical noise which may appear as false pulsatile information and cause incorrect readings.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Physiology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Spectrometry And Color Measurement (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/008343 WO1997001985A1 (en) | 1995-07-03 | 1995-07-03 | Apparatus for determining spectral absorption |
JP9505095A JPH11508691A (en) | 1995-07-03 | 1995-07-03 | Spectral absorption measurement device |
EP95925446A EP0901338A1 (en) | 1995-07-03 | 1995-07-03 | Apparatus for determining spectral absorption |
AU29576/95A AU716502B2 (en) | 1995-07-03 | 1995-07-03 | Apparatus for determining spectral absorption |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/008343 WO1997001985A1 (en) | 1995-07-03 | 1995-07-03 | Apparatus for determining spectral absorption |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997001985A1 true WO1997001985A1 (en) | 1997-01-23 |
Family
ID=22249411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/008343 WO1997001985A1 (en) | 1995-07-03 | 1995-07-03 | Apparatus for determining spectral absorption |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0901338A1 (en) |
JP (1) | JPH11508691A (en) |
AU (1) | AU716502B2 (en) |
WO (1) | WO1997001985A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062400A1 (en) * | 1998-06-03 | 1999-12-09 | Perdue Holdings, Inc. | Partially rigid-partially flexible electro-optical sensor for fingertip transillumination |
US6444970B1 (en) | 1998-06-26 | 2002-09-03 | Scimed Life Systems, Inc. | Miniature low-noise photodiode system |
WO2006123098A3 (en) * | 2005-05-16 | 2007-01-11 | Hutchinson Technology | Patient interface for spectroscopy applications |
US7460897B1 (en) | 2005-05-16 | 2008-12-02 | Hutchinson Technology Incorporated | Patient interface for spectroscopy applications |
US8140148B2 (en) | 1998-01-20 | 2012-03-20 | Boston Scientific Scimed Ltd. | Readable probe array for in vivo use |
US8849365B2 (en) | 2005-03-01 | 2014-09-30 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US8965471B2 (en) | 2007-04-21 | 2015-02-24 | Cercacor Laboratories, Inc. | Tissue profile wellness monitor |
US9839381B1 (en) | 2009-11-24 | 2017-12-12 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
US9907494B2 (en) | 2012-04-18 | 2018-03-06 | Hutchinson Technology Incorporated | NIRS device with optical wavelength and path length correction |
US10729402B2 (en) | 2009-12-04 | 2020-08-04 | Masimo Corporation | Calibration for multi-stage physiological monitors |
US11426103B2 (en) | 2008-07-03 | 2022-08-30 | Masimo Corporation | Multi-stream data collection system for noninvasive measurement of blood constituents |
US11638532B2 (en) | 2008-07-03 | 2023-05-02 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US12029586B2 (en) | 2006-10-12 | 2024-07-09 | Masimo Corporation | Oximeter probe off indicator defining probe off space |
US12114974B2 (en) | 2020-01-13 | 2024-10-15 | Masimo Corporation | Wearable device with physiological parameters monitoring |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE41912E1 (en) | 1998-10-15 | 2010-11-02 | Masimo Corporation | Reusable pulse oximeter probe and disposable bandage apparatus |
US6343224B1 (en) * | 1998-10-15 | 2002-01-29 | Sensidyne, Inc. | Reusable pulse oximeter probe and disposable bandage apparatus |
US6721585B1 (en) | 1998-10-15 | 2004-04-13 | Sensidyne, Inc. | Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices |
JP5192971B2 (en) * | 2008-10-01 | 2013-05-08 | 浜松ホトニクス株式会社 | Probe for optical biometric device and optical biometric device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5058588A (en) * | 1989-09-19 | 1991-10-22 | Hewlett-Packard Company | Oximeter and medical sensor therefor |
US5069213A (en) * | 1988-04-29 | 1991-12-03 | Thor Technology Corporation | Oximeter sensor assembly with integral cable and encoder |
US5209230A (en) * | 1990-10-19 | 1993-05-11 | Nellcor Incorporated | Adhesive pulse oximeter sensor with reusable portion |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4700708A (en) * | 1982-09-02 | 1987-10-20 | Nellcor Incorporated | Calibrated optical oximeter probe |
ATE51134T1 (en) * | 1982-09-02 | 1990-04-15 | Nellcor Inc | CALIBRATED OPTICAL OXYMETRY PROBE. |
US5273041A (en) * | 1992-04-30 | 1993-12-28 | General Electric Company | Fiber optic photoplethysmograph for a magnetic resonance imaging system |
-
1995
- 1995-07-03 JP JP9505095A patent/JPH11508691A/en not_active Ceased
- 1995-07-03 WO PCT/US1995/008343 patent/WO1997001985A1/en not_active Application Discontinuation
- 1995-07-03 AU AU29576/95A patent/AU716502B2/en not_active Ceased
- 1995-07-03 EP EP95925446A patent/EP0901338A1/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5069213A (en) * | 1988-04-29 | 1991-12-03 | Thor Technology Corporation | Oximeter sensor assembly with integral cable and encoder |
US5058588A (en) * | 1989-09-19 | 1991-10-22 | Hewlett-Packard Company | Oximeter and medical sensor therefor |
US5209230A (en) * | 1990-10-19 | 1993-05-11 | Nellcor Incorporated | Adhesive pulse oximeter sensor with reusable portion |
Non-Patent Citations (1)
Title |
---|
See also references of EP0901338A4 * |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8140148B2 (en) | 1998-01-20 | 2012-03-20 | Boston Scientific Scimed Ltd. | Readable probe array for in vivo use |
WO1999062400A1 (en) * | 1998-06-03 | 1999-12-09 | Perdue Holdings, Inc. | Partially rigid-partially flexible electro-optical sensor for fingertip transillumination |
US6444970B1 (en) | 1998-06-26 | 2002-09-03 | Scimed Life Systems, Inc. | Miniature low-noise photodiode system |
US11430572B2 (en) | 2005-03-01 | 2022-08-30 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US9351675B2 (en) | 2005-03-01 | 2016-05-31 | Cercacor Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US10327683B2 (en) | 2005-03-01 | 2019-06-25 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US10251585B2 (en) | 2005-03-01 | 2019-04-09 | Cercacor Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US8849365B2 (en) | 2005-03-01 | 2014-09-30 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US8912909B2 (en) | 2005-03-01 | 2014-12-16 | Cercacor Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US8929964B2 (en) | 2005-03-01 | 2015-01-06 | Cercacor Laboratories, Inc. | Multiple wavelength sensor drivers |
US10123726B2 (en) | 2005-03-01 | 2018-11-13 | Cercacor Laboratories, Inc. | Configurable physiological measurement system |
US9131882B2 (en) | 2005-03-01 | 2015-09-15 | Cercacor Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US9167995B2 (en) | 2005-03-01 | 2015-10-27 | Cercacor Laboratories, Inc. | Physiological parameter confidence measure |
US9241662B2 (en) | 2005-03-01 | 2016-01-26 | Cercacor Laboratories, Inc. | Configurable physiological measurement system |
US10984911B2 (en) | 2005-03-01 | 2021-04-20 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US9549696B2 (en) | 2005-03-01 | 2017-01-24 | Cercacor Laboratories, Inc. | Physiological parameter confidence measure |
US9750443B2 (en) | 2005-03-01 | 2017-09-05 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US11545263B2 (en) | 2005-03-01 | 2023-01-03 | Cercacor Laboratories, Inc. | Multiple wavelength sensor emitters |
US10856788B2 (en) | 2005-03-01 | 2020-12-08 | Cercacor Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US7596397B2 (en) | 2005-05-16 | 2009-09-29 | Hutchinson Technology Incorporated | Patient interface for spectroscopy applications |
US8473019B2 (en) | 2005-05-16 | 2013-06-25 | Hutchinson Technology Incorporated | Patient interface for spectroscopy applications |
WO2006123098A3 (en) * | 2005-05-16 | 2007-01-11 | Hutchinson Technology | Patient interface for spectroscopy applications |
US7460897B1 (en) | 2005-05-16 | 2008-12-02 | Hutchinson Technology Incorporated | Patient interface for spectroscopy applications |
US12029586B2 (en) | 2006-10-12 | 2024-07-09 | Masimo Corporation | Oximeter probe off indicator defining probe off space |
US10251586B2 (en) | 2007-04-21 | 2019-04-09 | Masimo Corporation | Tissue profile wellness monitor |
US11647923B2 (en) | 2007-04-21 | 2023-05-16 | Masimo Corporation | Tissue profile wellness monitor |
US8965471B2 (en) | 2007-04-21 | 2015-02-24 | Cercacor Laboratories, Inc. | Tissue profile wellness monitor |
US9848807B2 (en) | 2007-04-21 | 2017-12-26 | Masimo Corporation | Tissue profile wellness monitor |
US10980457B2 (en) | 2007-04-21 | 2021-04-20 | Masimo Corporation | Tissue profile wellness monitor |
US11638532B2 (en) | 2008-07-03 | 2023-05-02 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US11751773B2 (en) | 2008-07-03 | 2023-09-12 | Masimo Corporation | Emitter arrangement for physiological measurements |
US11642037B2 (en) | 2008-07-03 | 2023-05-09 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US11642036B2 (en) | 2008-07-03 | 2023-05-09 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US11484229B2 (en) | 2008-07-03 | 2022-11-01 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US12036009B1 (en) | 2008-07-03 | 2024-07-16 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US12023139B1 (en) | 2008-07-03 | 2024-07-02 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US11647914B2 (en) | 2008-07-03 | 2023-05-16 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US11484230B2 (en) | 2008-07-03 | 2022-11-01 | Masimo Corporation | User-worn device for noninvasively measuring a physiological parameter of a user |
US11426103B2 (en) | 2008-07-03 | 2022-08-30 | Masimo Corporation | Multi-stream data collection system for noninvasive measurement of blood constituents |
US10750983B2 (en) | 2009-11-24 | 2020-08-25 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
US9839381B1 (en) | 2009-11-24 | 2017-12-12 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
US11534087B2 (en) | 2009-11-24 | 2022-12-27 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
US11571152B2 (en) | 2009-12-04 | 2023-02-07 | Masimo Corporation | Calibration for multi-stage physiological monitors |
US10729402B2 (en) | 2009-12-04 | 2020-08-04 | Masimo Corporation | Calibration for multi-stage physiological monitors |
US9907494B2 (en) | 2012-04-18 | 2018-03-06 | Hutchinson Technology Incorporated | NIRS device with optical wavelength and path length correction |
US11045122B2 (en) | 2012-04-18 | 2021-06-29 | Fortiori Design Llc | NIRS device with optical wavelength and path length correction |
US12114974B2 (en) | 2020-01-13 | 2024-10-15 | Masimo Corporation | Wearable device with physiological parameters monitoring |
Also Published As
Publication number | Publication date |
---|---|
EP0901338A1 (en) | 1999-03-17 |
EP0901338A4 (en) | 1999-03-17 |
AU2957695A (en) | 1997-02-05 |
AU716502B2 (en) | 2000-02-24 |
JPH11508691A (en) | 1999-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5429129A (en) | Apparatus for determining spectral absorption by a specific substance in a fluid | |
AU716502B2 (en) | Apparatus for determining spectral absorption | |
US9498158B2 (en) | Optical sensor path selection | |
JP5009309B2 (en) | Sensor system with memory and method of using the sensor | |
US4926867A (en) | Light-reflecting and heating type oximeter | |
US4865038A (en) | Sensor appliance for non-invasive monitoring | |
CA1298484C (en) | Method and apparatus for the automatic calibration of signals employed in oximetry | |
US6934570B2 (en) | Physiological sensor combination | |
US6298252B1 (en) | Oximeter sensor with encoder connected to detector | |
US7680522B2 (en) | Method and apparatus for detecting misapplied sensors | |
US6760610B2 (en) | Sensor and method for measurement of physiological parameters | |
US7526328B2 (en) | Manual and automatic probe calibration | |
US20060020185A1 (en) | Cyanotic infant sensor | |
KR101033472B1 (en) | Method and shape of sensor module for photo-plethysmogram measurement without motion artifact | |
WO2000018290A9 (en) | Oximeter sensor with encoded temperature characteristic | |
CA2421607A1 (en) | Oximeter sensor adapter with coding element | |
JPS5964031A (en) | Probe of correctable optical oxygen densitometer | |
JPS63130045A (en) | Bonding sensor | |
US10925526B2 (en) | Heating oximeter | |
US20090012380A1 (en) | Deformable physiological sensor | |
EP1771109B1 (en) | Cyanotic infant sensor | |
CA2466105C (en) | Sensor and method for measuring physiological parameters | |
US4458518A (en) | Apparatus and method for calibrating a photoplethysmograph | |
JP3422149B2 (en) | Biological tissue oxygen monitor | |
Podlepetskii et al. | Microelectronic transducers and converters for noninvasive monitoring of the functional systems of humans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TT UA UG UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 505095 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995925446 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1995925446 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995925446 Country of ref document: EP |